サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1788305

肺ステントの世界市場

Pulmonary Stents

出版日
ページ情報
英文 170 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.66円
肺ステントの世界市場
出版日: 2025年08月12日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 170 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

肺ステントの世界市場は2030年までに3億3,110万米ドルに達する見込み

2024年に2億4,880万米ドルと推定される肺ステントの世界市場は、2024年から2030年にかけてCAGR 4.9%で成長し、2030年には3億3,110万米ドルに達すると予測されます。本レポートで分析したセグメントの1つである自己拡張型ステントは、CAGR 5.8%を記録し、分析期間終了時には2億2,150万米ドルに達すると予測されます。バルーン拡張型ステントセグメントの成長率は、分析期間中CAGR 3.2%と推定されます。

米国市場は6,540万米ドルと推定、中国はCAGR4.7%で成長予測

米国の肺ステント市場は、2024年に6,540万米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに5,320万米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは4.7%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ4.6％と4.2％と予測されています。欧州では、ドイツがCAGR 3.9%で成長すると予測されています。

世界の肺ステント市場- 主要動向と促進要因のまとめ

肺ステントが呼吸器医療に欠かせなくなった理由とは？

肺ステントは、気管気管支狭窄、肺がん、慢性閉塞性肺疾患（COPD）、外科手術後の合併症などの疾患による気道閉塞の管理に重要な役割を果たしています。これらのステントは気道の開存性を維持するのに役立ち、患者の呼吸を楽にし、全体的な生活の質を向上させます。環境汚染、喫煙、高齢化により呼吸器疾患の有病率が上昇を続ける中、肺ステントの需要は大きく伸びています。侵襲的な外科的処置とは異なり、気管支鏡によるステント留置は低侵襲のソリューションを提供し、患者の回復時間と入院期間を短縮します。呼吸器ケアにおいて外科的処置を必要としない治療法が好まれるようになったことで、肺ステント技術の進歩が促進され、より効果的で耐久性のある生体適合性の高いステントが開発されるようになりました。ヘルスケアプロバイダーは、複雑な気道疾患を管理するための治療プロトコルに肺ステントを取り入れることが増えており、世界中の病院や専門クリニックで採用が広がっています。

技術の進歩によって肺ステントの性能はどのように向上しているのでしょうか？

肺ステントのデザインと材料における最近の技術革新は、その臨床効果と患者の転帰を著しく向上させています。従来の金属製ステントやシリコン製ステントは、移行のリスクを最小限に抑え、気道内での長期安定性を向上させるために改良されてきました。気道の輪郭に順応し、頻繁な位置変更の必要性を減らす自己拡張型ステントの導入は、手技の成功率を向上させました。さらに、抗炎症剤や抗増殖剤でコーティングされた薬剤溶出性ステントは、再狭窄を予防し、インターベンションを繰り返す可能性を減らすために開発されています。時間の経過とともに徐々に溶解する生体吸収性ステントは、一時的な気道支持のための有望な選択肢として台頭してきており、ステント除去処置の必要性を排除しています。また、高解像度CTスキャンやガイド下気管支鏡などの画像技術の向上により、ステント留置の精度が向上し、合併症が減少して治療成績が最適化されています。ステントの柔軟性、生体適合性、および長期的な有効性の向上に焦点を当てた調査が続けられているため、次世代の肺ステントは呼吸器医療における新たな基準を打ち立てるものと期待されています。

肺ステントの採用を促進する要因とは？

肺疾患の有病率の増加と、低侵襲治療オプションに対する意識の高まりが、肺ステントの需要を促進しています。患者やヘルスケアプロバイダーは、リスクが低く、回復が早く、患者の快適性が向上しているため、従来の開腹手術よりも気管支鏡下ステント留置術を支持しています。特に高齢化社会における肺がん罹患率の増加は、気道管理ソリューションの必要性をさらに加速させており、肺ステントは進行期がん患者の緩和ケアに広く使用されています。さらに、大気汚染や喫煙習慣に起因するCOPD患者の世界の増加により、気道閉塞を効果的に管理するためのステント留置が増加しています。金属とシリコーンの利点を組み合わせたハイブリッド設計など、ステント製造における技術的進歩も、耐久性と機能性の向上により市場の成長に寄与しています。多くの先進国で肺介入に対する償還政策が利用可能であることが、病院や専門クリニックが気道管理にこれらのデバイスを採用することをさらに後押ししています。

肺ステント市場の成長を促進する主な要因は？

世界の肺ステント市場の成長は、慢性呼吸器疾患の罹患率の上昇、ステント設計と材料の進歩、低侵襲的気道管理技術の採用増加など、いくつかの重要な要因によってもたらされます。特に新興市場におけるヘルスケアインフラの拡大は、高度な呼吸器治療へのアクセスを改善し、肺ステントの需要を押し上げています。また、AIを活用した画像処理とロボット支援気管支鏡の統合により、手技の精度が向上し、ステント留置がより効果的になり、合併症発生率が低下しています。さらに、ヘルスケアプロバイダー、研究機関、医療機器メーカーによる呼吸器ケアへの投資の拡大が、肺ステント技術の革新を加速させています。次世代ステントに対する規制当局の承認は、医療機器メーカーとヘルスケア機関との協力関係の増加とともに、市場拡大をさらに後押ししています。効果的な気道管理ソリューションへの需要が拡大し続ける中、肺ステント市場は、呼吸器ケアの未来を形作る継続的な進歩とともに、持続的な開拓の態勢を整えています。

セグメント

製品（自己拡張型ステント、バルーン拡張型ステント）、材料（金属、シリコン、ハイブリッド）、タイプ（気管気管支ステント、喉頭ステント）

調査対象企業の例

  • Abbott
  • B. Braun Melsungen AG
  • Bayer AG
  • Bess Medizintechnik GmbH
  • Biosensors International Group, Ltd.
  • BIOTRONIK SE & Co. KG
  • Boston Scientific Corporation
  • Cardinal Health, Inc.（Cordis）
  • Cook Group
  • E. Benson Hood Laboratories, Inc.
  • EFER ENDOSCOPY
  • ENDO-FLEX GmbH
  • GlaxoSmithKline plc
  • Johnson & Johnson Services, Inc.
  • Lepu Medical Technology
  • M.I. Tech
  • Medtronic plc
  • Merit Medical Systems, Inc.
  • MicroPort Scientific Corporation
  • Micro-Tech（Nanjing）Co., Ltd.

AI統合

当社は、有効な専門家コンテンツとAIツールにより、市場情報と競合情報を変革しています。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

第4章 競合

目次
Product Code: MCP32727

Global Pulmonary Stents Market to Reach US$331.1 Million by 2030

The global market for Pulmonary Stents estimated at US$248.8 Million in the year 2024, is expected to reach US$331.1 Million by 2030, growing at a CAGR of 4.9% over the analysis period 2024-2030. Self-expandable Stents, one of the segments analyzed in the report, is expected to record a 5.8% CAGR and reach US$221.5 Million by the end of the analysis period. Growth in the Balloon-expandable Stents segment is estimated at 3.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$65.4 Million While China is Forecast to Grow at 4.7% CAGR

The Pulmonary Stents market in the U.S. is estimated at US$65.4 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$53.2 Million by the year 2030 trailing a CAGR of 4.7% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.6% and 4.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.9% CAGR.

Global Pulmonary Stents Market - Key Trends & Drivers Summarized

Why Are Pulmonary Stents Becoming Essential in Respiratory Medicine?

Pulmonary stents play a crucial role in managing airway obstruction caused by conditions such as tracheobronchial stenosis, lung cancer, chronic obstructive pulmonary disease (COPD), and post-surgical complications. These stents help maintain airway patency, allowing patients to breathe more easily and improving overall quality of life. As the prevalence of respiratory disorders continues to rise due to environmental pollution, smoking, and aging populations, the demand for pulmonary stents has grown significantly. Unlike invasive surgical procedures, stent placement via bronchoscopy offers a minimally invasive solution, reducing patient recovery time and hospital stays. The increasing preference for non-surgical interventions in respiratory care has driven advancements in pulmonary stent technology, making them more effective, durable, and biocompatible. Healthcare providers are increasingly incorporating pulmonary stents into treatment protocols to manage complex airway diseases, leading to expanded adoption across hospitals and specialty clinics worldwide.

How Are Technological Advancements Improving Pulmonary Stent Performance?

Recent innovations in pulmonary stent design and materials have significantly enhanced their clinical efficacy and patient outcomes. Traditional metal and silicone stents have been refined to minimize migration risks and improve long-term stability within the airways. The introduction of self-expanding stents, which adapt to airway contours and reduce the need for frequent repositioning, has improved procedural success rates. Furthermore, drug-eluting pulmonary stents, coated with anti-inflammatory or anti-proliferative agents, are being developed to prevent restenosis and reduce the likelihood of repeat interventions. Bioresorbable stents, which gradually dissolve over time, are emerging as a promising alternative for temporary airway support, eliminating the need for stent removal procedures. Enhanced imaging technologies such as high-resolution CT scans and guided bronchoscopy have also improved the precision of stent placement, reducing complications and optimizing treatment outcomes. As research continues to focus on improving stent flexibility, biocompatibility, and long-term efficacy, the next generation of pulmonary stents is expected to set new standards in respiratory medicine.

What Factors Are Driving the Adoption of Pulmonary Stents?

The increasing prevalence of lung diseases, coupled with rising awareness about minimally invasive treatment options, has fueled the demand for pulmonary stents. Patients and healthcare providers are favoring bronchoscopic stenting over traditional open surgeries due to lower risks, faster recovery times, and improved patient comfort. The rising incidence of lung cancer, particularly in aging populations, has further accelerated the need for airway management solutions, with pulmonary stents being widely used for palliative care in advanced-stage cancer patients. Additionally, the growing number of COPD cases worldwide, driven by air pollution and smoking habits, has led to increased stent placements to manage airway obstruction effectively. Technological advancements in stent manufacturing, such as hybrid designs that combine the benefits of metal and silicone, are also contributing to market growth by offering enhanced durability and functionality. The availability of reimbursement policies for pulmonary interventions in many developed countries is further encouraging hospitals and specialty clinics to adopt these devices for airway management.

What Are the Key Drivers Fueling Growth in the Pulmonary Stents Market?

The growth in the global pulmonary stents market is driven by several key factors, including the rising incidence of chronic respiratory diseases, advancements in stent design and materials, and the increasing adoption of minimally invasive airway management techniques. The expansion of healthcare infrastructure, particularly in emerging markets, is improving access to advanced respiratory treatments, boosting demand for pulmonary stents. The integration of AI-powered imaging and robotic-assisted bronchoscopy is also enhancing procedural accuracy, making stent placement more effective and reducing complication rates. Furthermore, the growing investment in respiratory care by healthcare providers, research institutions, and medical device manufacturers is accelerating innovation in pulmonary stent technology. Regulatory approvals for next-generation stents, along with increasing collaborations between medical device companies and healthcare organizations, are further driving market expansion. As the demand for effective airway management solutions continues to grow, the pulmonary stents market is poised for sustained development, with ongoing advancements shaping the future of respiratory care.

SCOPE OF STUDY:

The report analyzes the Pulmonary Stents market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Self-expandable Stents, Balloon-expandable Stents); Material (Metal, Silicon, Hybrid); Type (Tracheobronchial Stents, Laryngeal Stents)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 42 Featured) -

  • Abbott
  • B. Braun Melsungen AG
  • Bayer AG
  • Bess Medizintechnik GmbH
  • Biosensors International Group, Ltd.
  • BIOTRONIK SE & Co. KG
  • Boston Scientific Corporation
  • Cardinal Health, Inc. (Cordis)
  • Cook Group
  • E. Benson Hood Laboratories, Inc.
  • EFER ENDOSCOPY
  • ENDO-FLEX GmbH
  • GlaxoSmithKline plc
  • Johnson & Johnson Services, Inc.
  • Lepu Medical Technology
  • M.I. Tech
  • Medtronic plc
  • Merit Medical Systems, Inc.
  • MicroPort Scientific Corporation
  • Micro-Tech (Nanjing) Co., Ltd.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Pulmonary Stents - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Incidence of Tracheobronchial Obstructions and Airway Stenosis Throws the Spotlight on Pulmonary Stent Utilization
    • Expansion of Interventional Pulmonology and Minimally Invasive Airway Management Drives Adoption of Pulmonary Stents
    • Increasing Prevalence of COPD, Lung Cancer, and Post-Intubation Stenosis Strengthens Business Case for Airway Stenting
    • Advancements in Stent Design, Flexibility, and Radial Force Propel Innovation in Customized Pulmonary Stents
    • Surge in Geriatric Population and Age-Related Respiratory Disorders Drives Demand for Long-Term Airway Patency Solutions
    • Development of Drug-Eluting and Bioabsorbable Pulmonary Stents Expands the Therapeutic Scope for Chronic Pulmonary Conditions
    • Rising Adoption of 3D Printing and Patient-Specific Stent Models Enhances Procedural Precision and Clinical Outcomes
    • Integration of Bronchoscopic Navigation and Imaging Systems Improves Placement Accuracy and Procedural Safety
    • Growing Use of Temporary and Removable Silicone Stents Spurs Preference for Less Invasive and Reversible Airway Interventions
    • Regulatory Approvals and Reimbursement Policies Supporting Interventional Pulmonary Devices Propel Market Penetration
    • Increased Focus on Airway Rescue and Palliative Interventions in Advanced-Stage Oncology Boosts Pulmonary Stent Procedures
    • Emergence of Customized Hybrid Stents Combining Metal and Polymer Components Enhances Functional Performance
    • Collaborations Between Pulmonologists and Thoracic Surgeons Drive Adoption of Multidisciplinary Airway Management Approaches
    • Expansion of Specialized Centers for Complex Airway Disorders Spurs Training and Procedural Volumes Globally
    • Surging Demand for Pediatric Airway Stents Creates Opportunities for Miniaturized and Growth-Adaptive Device Designs
    • Focus on Reducing Granulation Tissue Formation and Migration Complications Drives Next-Generation Stent Development
    • Growth of Ambulatory Bronchoscopy Services Accelerates Use of Pulmonary Stents in Outpatient Settings
    • Rising Use of Pulmonary Stents in Emergency Airway Obstruction Scenarios Fuels Demand for Rapid-Deployment Systems
    • Investment in Clinical Trials and Real-World Evidence Collection Strengthens Regulatory Support and Market Confidence
    • Integration of Pulmonary Stents with Adjunctive Therapies Like Radiation and Chemotherapy Expands Multimodal Treatment Models
    • Expansion into Emerging Markets with Rising Respiratory Disease Burden Sustains Global Demand for Pulmonary Stenting Solutions
    • Focus on Sustainable Manufacturing and Biocompatible Materials Supports Eco-Efficient and Patient-Centric Innovation
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Pulmonary Stents Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Pulmonary Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World 6-Year Perspective for Pulmonary Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Self-expandable Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 5: World 6-Year Perspective for Self-expandable Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Balloon-expandable Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 7: World 6-Year Perspective for Balloon-expandable Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Metal by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World 6-Year Perspective for Metal by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Silicon by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 11: World 6-Year Perspective for Silicon by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Hybrid by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 13: World 6-Year Perspective for Hybrid by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Tracheobronchial Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World 6-Year Perspective for Tracheobronchial Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Laryngeal Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 17: World 6-Year Perspective for Laryngeal Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Pulmonary Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 18: USA Recent Past, Current & Future Analysis for Pulmonary Stents by Product - Self-expandable Stents and Balloon-expandable Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 19: USA 6-Year Perspective for Pulmonary Stents by Product - Percentage Breakdown of Value Sales for Self-expandable Stents and Balloon-expandable Stents for the Years 2025 & 2030
    • TABLE 20: USA Recent Past, Current & Future Analysis for Pulmonary Stents by Material - Metal, Silicon and Hybrid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 21: USA 6-Year Perspective for Pulmonary Stents by Material - Percentage Breakdown of Value Sales for Metal, Silicon and Hybrid for the Years 2025 & 2030
    • TABLE 22: USA Recent Past, Current & Future Analysis for Pulmonary Stents by Type - Tracheobronchial Stents and Laryngeal Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 23: USA 6-Year Perspective for Pulmonary Stents by Type - Percentage Breakdown of Value Sales for Tracheobronchial Stents and Laryngeal Stents for the Years 2025 & 2030
  • CANADA
    • TABLE 24: Canada Recent Past, Current & Future Analysis for Pulmonary Stents by Product - Self-expandable Stents and Balloon-expandable Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 25: Canada 6-Year Perspective for Pulmonary Stents by Product - Percentage Breakdown of Value Sales for Self-expandable Stents and Balloon-expandable Stents for the Years 2025 & 2030
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Pulmonary Stents by Material - Metal, Silicon and Hybrid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Canada 6-Year Perspective for Pulmonary Stents by Material - Percentage Breakdown of Value Sales for Metal, Silicon and Hybrid for the Years 2025 & 2030
    • TABLE 28: Canada Recent Past, Current & Future Analysis for Pulmonary Stents by Type - Tracheobronchial Stents and Laryngeal Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 29: Canada 6-Year Perspective for Pulmonary Stents by Type - Percentage Breakdown of Value Sales for Tracheobronchial Stents and Laryngeal Stents for the Years 2025 & 2030
  • JAPAN
    • Pulmonary Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 30: Japan Recent Past, Current & Future Analysis for Pulmonary Stents by Product - Self-expandable Stents and Balloon-expandable Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 31: Japan 6-Year Perspective for Pulmonary Stents by Product - Percentage Breakdown of Value Sales for Self-expandable Stents and Balloon-expandable Stents for the Years 2025 & 2030
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Pulmonary Stents by Material - Metal, Silicon and Hybrid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Japan 6-Year Perspective for Pulmonary Stents by Material - Percentage Breakdown of Value Sales for Metal, Silicon and Hybrid for the Years 2025 & 2030
    • TABLE 34: Japan Recent Past, Current & Future Analysis for Pulmonary Stents by Type - Tracheobronchial Stents and Laryngeal Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 35: Japan 6-Year Perspective for Pulmonary Stents by Type - Percentage Breakdown of Value Sales for Tracheobronchial Stents and Laryngeal Stents for the Years 2025 & 2030
  • CHINA
    • Pulmonary Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 36: China Recent Past, Current & Future Analysis for Pulmonary Stents by Product - Self-expandable Stents and Balloon-expandable Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 37: China 6-Year Perspective for Pulmonary Stents by Product - Percentage Breakdown of Value Sales for Self-expandable Stents and Balloon-expandable Stents for the Years 2025 & 2030
    • TABLE 38: China Recent Past, Current & Future Analysis for Pulmonary Stents by Material - Metal, Silicon and Hybrid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: China 6-Year Perspective for Pulmonary Stents by Material - Percentage Breakdown of Value Sales for Metal, Silicon and Hybrid for the Years 2025 & 2030
    • TABLE 40: China Recent Past, Current & Future Analysis for Pulmonary Stents by Type - Tracheobronchial Stents and Laryngeal Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 41: China 6-Year Perspective for Pulmonary Stents by Type - Percentage Breakdown of Value Sales for Tracheobronchial Stents and Laryngeal Stents for the Years 2025 & 2030
  • EUROPE
    • Pulmonary Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 42: Europe Recent Past, Current & Future Analysis for Pulmonary Stents by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 43: Europe 6-Year Perspective for Pulmonary Stents by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Pulmonary Stents by Product - Self-expandable Stents and Balloon-expandable Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Europe 6-Year Perspective for Pulmonary Stents by Product - Percentage Breakdown of Value Sales for Self-expandable Stents and Balloon-expandable Stents for the Years 2025 & 2030
    • TABLE 46: Europe Recent Past, Current & Future Analysis for Pulmonary Stents by Material - Metal, Silicon and Hybrid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 47: Europe 6-Year Perspective for Pulmonary Stents by Material - Percentage Breakdown of Value Sales for Metal, Silicon and Hybrid for the Years 2025 & 2030
    • TABLE 48: Europe Recent Past, Current & Future Analysis for Pulmonary Stents by Type - Tracheobronchial Stents and Laryngeal Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 49: Europe 6-Year Perspective for Pulmonary Stents by Type - Percentage Breakdown of Value Sales for Tracheobronchial Stents and Laryngeal Stents for the Years 2025 & 2030
  • FRANCE
    • Pulmonary Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 50: France Recent Past, Current & Future Analysis for Pulmonary Stents by Product - Self-expandable Stents and Balloon-expandable Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: France 6-Year Perspective for Pulmonary Stents by Product - Percentage Breakdown of Value Sales for Self-expandable Stents and Balloon-expandable Stents for the Years 2025 & 2030
    • TABLE 52: France Recent Past, Current & Future Analysis for Pulmonary Stents by Material - Metal, Silicon and Hybrid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 53: France 6-Year Perspective for Pulmonary Stents by Material - Percentage Breakdown of Value Sales for Metal, Silicon and Hybrid for the Years 2025 & 2030
    • TABLE 54: France Recent Past, Current & Future Analysis for Pulmonary Stents by Type - Tracheobronchial Stents and Laryngeal Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 55: France 6-Year Perspective for Pulmonary Stents by Type - Percentage Breakdown of Value Sales for Tracheobronchial Stents and Laryngeal Stents for the Years 2025 & 2030
  • GERMANY
    • Pulmonary Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 56: Germany Recent Past, Current & Future Analysis for Pulmonary Stents by Product - Self-expandable Stents and Balloon-expandable Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Germany 6-Year Perspective for Pulmonary Stents by Product - Percentage Breakdown of Value Sales for Self-expandable Stents and Balloon-expandable Stents for the Years 2025 & 2030
    • TABLE 58: Germany Recent Past, Current & Future Analysis for Pulmonary Stents by Material - Metal, Silicon and Hybrid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 59: Germany 6-Year Perspective for Pulmonary Stents by Material - Percentage Breakdown of Value Sales for Metal, Silicon and Hybrid for the Years 2025 & 2030
    • TABLE 60: Germany Recent Past, Current & Future Analysis for Pulmonary Stents by Type - Tracheobronchial Stents and Laryngeal Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 61: Germany 6-Year Perspective for Pulmonary Stents by Type - Percentage Breakdown of Value Sales for Tracheobronchial Stents and Laryngeal Stents for the Years 2025 & 2030
  • ITALY
    • TABLE 62: Italy Recent Past, Current & Future Analysis for Pulmonary Stents by Product - Self-expandable Stents and Balloon-expandable Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Italy 6-Year Perspective for Pulmonary Stents by Product - Percentage Breakdown of Value Sales for Self-expandable Stents and Balloon-expandable Stents for the Years 2025 & 2030
    • TABLE 64: Italy Recent Past, Current & Future Analysis for Pulmonary Stents by Material - Metal, Silicon and Hybrid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 65: Italy 6-Year Perspective for Pulmonary Stents by Material - Percentage Breakdown of Value Sales for Metal, Silicon and Hybrid for the Years 2025 & 2030
    • TABLE 66: Italy Recent Past, Current & Future Analysis for Pulmonary Stents by Type - Tracheobronchial Stents and Laryngeal Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 67: Italy 6-Year Perspective for Pulmonary Stents by Type - Percentage Breakdown of Value Sales for Tracheobronchial Stents and Laryngeal Stents for the Years 2025 & 2030
  • UNITED KINGDOM
    • Pulmonary Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 68: UK Recent Past, Current & Future Analysis for Pulmonary Stents by Product - Self-expandable Stents and Balloon-expandable Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: UK 6-Year Perspective for Pulmonary Stents by Product - Percentage Breakdown of Value Sales for Self-expandable Stents and Balloon-expandable Stents for the Years 2025 & 2030
    • TABLE 70: UK Recent Past, Current & Future Analysis for Pulmonary Stents by Material - Metal, Silicon and Hybrid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 71: UK 6-Year Perspective for Pulmonary Stents by Material - Percentage Breakdown of Value Sales for Metal, Silicon and Hybrid for the Years 2025 & 2030
    • TABLE 72: UK Recent Past, Current & Future Analysis for Pulmonary Stents by Type - Tracheobronchial Stents and Laryngeal Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 73: UK 6-Year Perspective for Pulmonary Stents by Type - Percentage Breakdown of Value Sales for Tracheobronchial Stents and Laryngeal Stents for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 74: Rest of Europe Recent Past, Current & Future Analysis for Pulmonary Stents by Product - Self-expandable Stents and Balloon-expandable Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Rest of Europe 6-Year Perspective for Pulmonary Stents by Product - Percentage Breakdown of Value Sales for Self-expandable Stents and Balloon-expandable Stents for the Years 2025 & 2030
    • TABLE 76: Rest of Europe Recent Past, Current & Future Analysis for Pulmonary Stents by Material - Metal, Silicon and Hybrid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 77: Rest of Europe 6-Year Perspective for Pulmonary Stents by Material - Percentage Breakdown of Value Sales for Metal, Silicon and Hybrid for the Years 2025 & 2030
    • TABLE 78: Rest of Europe Recent Past, Current & Future Analysis for Pulmonary Stents by Type - Tracheobronchial Stents and Laryngeal Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 79: Rest of Europe 6-Year Perspective for Pulmonary Stents by Type - Percentage Breakdown of Value Sales for Tracheobronchial Stents and Laryngeal Stents for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Pulmonary Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 80: Asia-Pacific Recent Past, Current & Future Analysis for Pulmonary Stents by Product - Self-expandable Stents and Balloon-expandable Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Asia-Pacific 6-Year Perspective for Pulmonary Stents by Product - Percentage Breakdown of Value Sales for Self-expandable Stents and Balloon-expandable Stents for the Years 2025 & 2030
    • TABLE 82: Asia-Pacific Recent Past, Current & Future Analysis for Pulmonary Stents by Material - Metal, Silicon and Hybrid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 83: Asia-Pacific 6-Year Perspective for Pulmonary Stents by Material - Percentage Breakdown of Value Sales for Metal, Silicon and Hybrid for the Years 2025 & 2030
    • TABLE 84: Asia-Pacific Recent Past, Current & Future Analysis for Pulmonary Stents by Type - Tracheobronchial Stents and Laryngeal Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 85: Asia-Pacific 6-Year Perspective for Pulmonary Stents by Type - Percentage Breakdown of Value Sales for Tracheobronchial Stents and Laryngeal Stents for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 86: Rest of World Recent Past, Current & Future Analysis for Pulmonary Stents by Product - Self-expandable Stents and Balloon-expandable Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Rest of World 6-Year Perspective for Pulmonary Stents by Product - Percentage Breakdown of Value Sales for Self-expandable Stents and Balloon-expandable Stents for the Years 2025 & 2030
    • TABLE 88: Rest of World Recent Past, Current & Future Analysis for Pulmonary Stents by Material - Metal, Silicon and Hybrid - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 89: Rest of World 6-Year Perspective for Pulmonary Stents by Material - Percentage Breakdown of Value Sales for Metal, Silicon and Hybrid for the Years 2025 & 2030
    • TABLE 90: Rest of World Recent Past, Current & Future Analysis for Pulmonary Stents by Type - Tracheobronchial Stents and Laryngeal Stents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 91: Rest of World 6-Year Perspective for Pulmonary Stents by Type - Percentage Breakdown of Value Sales for Tracheobronchial Stents and Laryngeal Stents for the Years 2025 & 2030

IV. COMPETITION